Introducing GSK GSK homepage Downloads Annual report
Product portfolio



Back Next
  Augmentin ANTI-BACTERIALS  
   


Augmentin

  
     

£1.22bn/$1.85bn

An antibiotic for the treatment of most common respiratory tract infections.

 

  
         
         
      back to list  

 
    Updated March 22, 2001 - © 2001 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement
Introducing GSK
Chairman and CEO
Business operating review
Corporate citizenship
Product portfolio
Corporate executive team
Summary financials
Summary remuneration report
Responsibility statements
Corporate governance
The board
Shareholder return
Shareholder information
Contact details